Simplex Trading
MRVI icon

Simplex Trading’s Maravai LifeSciences MRVI Stock Holding History

Simplex Trading’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104K Buy
+36,700
New +$124K ﹤0.01% 5037
2025
Q4 		– Sell
-204,600
Closed -$587K – 9500
2025
Q3 		$587K Sell
204,600
-36,400
-15% -$92.9K ﹤0.01% 3628
2025
Q2 		$580K Sell
241,000
-263,400
-52% -$554K ﹤0.01% 3340
2025
Q1 		$1.11M Buy
504,400
+402,900
+397% +$1.59M ﹤0.01% 2605
2024
Q4 		$553K Buy
101,500
+86,600
+581% +$557K ﹤0.01% 3418
2024
Q3 		$123K Sell
14,900
-5,000
-25% -$43.2K ﹤0.01% 5023
2024
Q2 		$142K Sell
19,900
-14,000
-41% -$121K ﹤0.01% 4994
2024
Q1 		$293K Buy
33,900
+31,600
+1,374% +$214K ﹤0.01% 4426
2023
Q4 		$15K Sell
2,300
-300
-12% -$1.94K ﹤0.01% 7143
2023
Q3 		$26K Buy
2,600
+700
+37% +$7.69K ﹤0.01% 6389
2023
Q2 		$23K Sell
1,900
-9,200
-83% -$124K ﹤0.01% 6636
2023
Q1 		$155K Buy
11,100
+9,700
+693% +$139K ﹤0.01% 4625
2022
Q4 		$20K Sell
1,400
-9,600
-87% -$151K ﹤0.01% 6873
2022
Q3 		$280K Buy
11,000
+10,700
+3,567% +$268K ﹤0.01% 4171
2022
Q2 		$8K Sell
300
-19,800
-99% -$627K ﹤0.01% 8483
2022
Q1 		$708K Buy
20,100
+15,500
+337% +$520K ﹤0.01% 3384
2021
Q4 		$192K Buy
4,600
+1,700
+59% +$68.9K ﹤0.01% 5258
2021
Q3 		$116K Buy
2,900
+100
+4% +$4.88K ﹤0.01% 6405
2021
Q2 		$116K Buy
2,800
+2,734
+4,142% +$106K ﹤0.01% 6515
2021
Q1 		$235K Sell
66
-177
-73% -$5.86K ﹤0.01% 4508
2020
Q4 		$681K Buy
+243
New +$6.77K ﹤0.01% 3046

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's MRVI Position: Q2 2024 in Review

Simplex Trading sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 14,764 shares — an estimated $127K sold.

Simplex Trading first reported a position in MRVI in Q1 2021 and held it in 12 quarters. The position peaked at $1.87M in Q2 2023. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

  • Simplex Trading reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Simplex Trading sold 14,764 Maravai LifeSciences shares in Q2 2024, an estimated $127K.
  • Simplex Trading first reported a position in Maravai LifeSciences in Q1 2021 and held it in 12 quarters.
  • Simplex Trading's Maravai LifeSciences position peaked at $1.87M in Q2 2023.
  • 206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.